Total Payments
$4,438
2024 Payments
$1,100
Companies
33
Transactions
313
Medicare Patients
916
Medicare Billing
$91,467
Payment Breakdown by Category
Food & Beverage$4,438 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,438 | 313 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $975.47 | 75 | $0 (2024) |
| GlaxoSmithKline, LLC. | $660.39 | 50 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $558.03 | 35 | $0 (2024) |
| ABBVIE INC. | $276.96 | 20 | $0 (2024) |
| PFIZER INC. | $244.51 | 16 | $0 (2024) |
| Astellas Pharma US Inc | $222.59 | 15 | $0 (2024) |
| Amgen Inc. | $218.55 | 16 | $0 (2024) |
| Merck Sharp & Dohme LLC | $187.02 | 14 | $0 (2024) |
| Lilly USA, LLC | $179.32 | 11 | $0 (2024) |
| Amarin Pharma Inc. | $122.12 | 9 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,100 | 68 | AstraZeneca Pharmaceuticals LP ($211.90) |
| 2023 | $349.22 | 22 | GlaxoSmithKline, LLC. ($48.62) |
| 2022 | $198.92 | 13 | Novo Nordisk Inc ($59.01) |
| 2021 | $509.83 | 37 | GlaxoSmithKline, LLC. ($191.03) |
| 2020 | $654.86 | 51 | GlaxoSmithKline, LLC. ($175.73) |
| 2019 | $979.91 | 75 | Novo Nordisk Inc ($264.47) |
| 2018 | $516.61 | 39 | Novo Nordisk Inc ($151.59) |
| 2017 | $128.74 | 8 | AstraZeneca Pharmaceuticals LP ($55.10) |
All Payment Transactions
313 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.97 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Oncology | ||||||
| 10/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Respiratory | ||||||
| 10/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Biological | ||||||
| 09/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Diabetes Care | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Biological | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Respiratory | ||||||
| 08/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: VACCINES | ||||||
| 08/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Diabetes | ||||||
| 08/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 285 | 331 | $74,664 | $30,099 |
| 2022 | 7 | 253 | 326 | $70,663 | $25,521 |
| 2021 | 5 | 174 | 235 | $50,148 | $19,222 |
| 2020 | 6 | 204 | 259 | $45,304 | $16,625 |
Total Patients
916
Total Services
1,151
Medicare Billing
$91,467
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 77 | 77 | $22,099 | $10,833 | 49.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 103 | $28,943 | $9,419 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 62 | $12,338 | $4,134 | 33.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $5,819 | $3,107 | 53.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 18 | 18 | $2,646 | $1,295 | 48.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $1,340 | $657.40 | 49.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $868.00 | $460.18 | 53.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 13 | $533.00 | $148.99 | 28.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 12 | 13 | $78.00 | $44.33 | 56.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 121 | $34,136 | $11,023 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 97 | $19,345 | $6,028 | 31.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 37 | 37 | $10,421 | $5,319 | 51.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 21 | 21 | $2,931 | $1,436 | 49.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 25 | 25 | $1,622 | $812.91 | 50.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 12 | 13 | $1,612 | $509.63 | 31.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 12 | $596.00 | $392.52 | 65.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 54 | 78 | $21,876 | $6,964 | 31.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 43 | 43 | $10,922 | $6,310 | 57.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 85 | $16,728 | $5,633 | 33.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 14 | 14 | $532.00 | $263.62 | 49.6% |
| 81002 | Urinalysis, manual test | Office | 2021 | 11 | 15 | $90.00 | $52.20 | 58.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 58 | 84 | $19,972 | $6,399 | 32.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 53 | 78 | $12,927 | $4,289 | 33.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 27 | 27 | $6,858 | $3,472 | 50.6% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 21 | 22 | $2,692 | $1,335 | 49.6% |
About Dr. Erica Milas, DO
Dr. Erica Milas, DO is a Family Medicine healthcare provider based in Paulsboro, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1518092428.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Erica Milas, DO has received a total of $4,438 in payments from pharmaceutical and medical device companies, with $1,100 received in 2024. These payments were reported across 313 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($4,438).
As a Medicare-enrolled provider, Milas has provided services to 916 Medicare beneficiaries, totaling 1,151 services with total Medicare billing of $91,467. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Paulsboro, NJ
- Active Since 02/22/2007
- Last Updated 07/02/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1518092428
Products in Payments
- Ozempic (Drug) $468.52
- TRELEGY ELLIPTA (Drug) $318.63
- FARXIGA (Drug) $238.86
- Saxenda (Drug) $165.99
- JANUVIA (Drug) $152.10
- VRAYLAR (Drug) $132.25
- ANORO ELLIPTA (Drug) $129.07
- SYMBICORT (Drug) $124.20
- Vascepa (Drug) $122.12
- MOUNJARO (Drug) $117.61
- BREZTRI (Drug) $112.72
- Livalo (Drug) $111.56
- Veozah (Drug) $109.92
- QULIPTA (Drug) $109.49
- NURTEC ODT (Drug) $104.52
- Rybelsus (Drug) $100.07
- MYRBETRIQ (Drug) $97.67
- Victoza (Drug) $91.25
- FREESTYLE LIBRE 3 (Device) $88.78
- AIRSUPRA (Drug) $82.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.